Quick Answer
Opus Genetics, Inc. reported Net Income Loss of -$49.59 million for the year ending 2025.
- Opus Genetics, Inc. showed an increase of +13.8% in Net Income Loss from 2024 to 2025.
- This data is from Opus Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2003 to 2025 (23 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2014: -$2.21 million | Q1 2015: -$4.27 million | Q2 2015: -$3.23 million | Q3 2015: -$4.03 million | Q4 2015: -$2.85 million | Q1 2016: -$4.15 million | Q2 2016: -$1.77 million | Q3 2016: -$2.87 million | Q4 2016: -$525.5 thousand | Q1 2017: -$21.61 million | Q2 2017: $947.1 thousand | Q3 2017: -$1.04 million | Q4 2017: -$3.59 million | Q1 2018: -$2.07 million | Q2 2018: -$3.84 million | Q3 2018: -$5.34 million | Q4 2018: -$3.12 million | Q1 2019: -$2.34 million | Q2 2019: -$2.46 million | Q3 2019: -$1.96 million | Q1 2020: -$3.09 million | Q2 2020: -$1.60 million | Q3 2020: -$1.25 million | Q1 2021: -$39.01 million | Q2 2021: -$7.14 million | Q3 2021: -$4.23 million | Q1 2022: -$6.60 million | Q2 2022: -$4.93 million | Q3 2022: -$4.53 million | Q1 2023: -$5.79 million | Q2 2023: -$4.96 million | Q3 2023: $5.56 million | Q1 2024: -$7.11 million | Q2 2024: -$7.77 million | Q3 2024: -$7.53 million | Q1 2025: -$8.19 million | Q2 2025: -$7.42 million | Q3 2025: -$17.45 million.
- Over the full 23 years of available data (2003 to 2025), Opus Genetics, Inc.'s Net Income Loss has declined by 1,687.0%.
- Historical annual values: Fiscal year 2025: -$49.59 million | Fiscal year 2024: -$57.53 million | Fiscal year 2023: -$9.99 million | Fiscal year 2022: $17.89 million | Fiscal year 2021: -$56.69 million | Fiscal year 2020: -$24.62 million | Fiscal year 2019: -$6.17 million | Fiscal year 2018: -$14.37 million | Fiscal year 2017: -$25.29 million | Fiscal year 2016: -$9.31 million | Fiscal year 2015: -$14.38 million | Fiscal year 2014: -$18.52 million | Fiscal year 2013: -$9.50 million | Fiscal year 2012: -$6.23 million | Fiscal year 2011: -$11.34 million | Fiscal year 2010: -$14.02 million | Fiscal year 2009: -$2.90 million | Fiscal year 2008: -$3.68 million | Fiscal year 2007: -$4.44 million | Fiscal year 2006: -$6.49 million | Fiscal year 2005: -$6.35 million | Fiscal year 2004: -$3.27 million | Fiscal year 2003: -$2.78 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: